VRAX — Virax Biolabs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Virax Biolabs, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	20-F	10-K	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.018	0.022	9.35	3.59	4.23
Net Total Accounts Receivable
Net Total Receivables	0.001	0	—	0.218	0.031
Total Inventory
Prepaid Expenses
Total Current Assets	0.04	0.049	9.63	4.38	4.89
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	—	1.1	1.53
Net Intangible Assets
Total Assets	0.04	0.049	9.81	5.48	6.43
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.871	1.25	0.908	0.169	0.673
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	0.69	1.02	0.686	0.117	0.731
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.651	-0.975	9.13	5.37	5.7
Total Liabilities & Shareholders' Equity	0.04	0.049	9.81	5.48	6.43
Total Common Shares Outstanding